NNC0442-0344 A

Phase 1Small molecule

Novo Nordisk

NNC0442-0344 A is one of 5 small molecule programs targeting Haemophilia A. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Haemophilia aRecruiting

Haemophilia aPhase 1

Recruiting

Competition

Competitive Landscape

5 competitors in Haemophilia a

#DrugCompanyPhaseTrials

ALHEMO

Novo Nordisk

Phase 3

2 2

Efanesoctocog Alfa

Sanofi

Phase 3

1 3

Mim8

Novo Nordisk

Phase 3

2 4

Nuwiq

Octapharma

Phase 3

2 5

NNC0442-0344 A

Novo Nordisk

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 1Recruiting

Haemophilia a

NCT07220564

Clinical

Trials by Indication[1]

Haemophilia A1 trial

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Peroral Doses of Inno8 in People With Haemophilia A

Recruiting· Novo Nordisk logo

Novo Nordisk·Phase 1·NCT07220564·30 enrolled

Unspecified2 trials

A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men

Recruiting· Novo Nordisk logo

Novo Nordisk·Phase 1·NCT06649630·108 enrolled

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

Recruiting· Novo Nordisk logo

Novo Nordisk·Phase 1·NCT07238816·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for NNC0442-0344 A. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NNC0442-0344 A compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NNC0442-0344 A. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Novo Nordisk company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Novo Nordisk

NNC0442-0344 A

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Haemophilia A1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News